Part Number : NDC00173-0393-40 | Manufacturer : Glaxowellcome | ||
NSN : 6505-01-230-6004 (6505012306004) | |||
Item Name : Ranitidine Tablets Usp | CAGE Code : 34006 | ||
NIIN : 01-230-6004 (012306004) | |||
INC Code : 42733 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00173039340 |
Thank you for taking an interest in part number NDC00173-0393-40, that of which is listed with the description Ranitidine Tablets Usp; Manufactured by Glaxowellcome and listed alongside the NSN 6505012306004, part number NDC00173-0393-40 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00173-0393-40 | Manufacturer : Glaxowellcome | ||
NSN Number : 6505-01-230-6004 (6505012306004) | |||
Item Name : Ranitidine Tablets Usp | CAGE Code : 34006 | ||
NIIN : 012306004 |
Thank you for taking an interest in part number NDC00173-0393-40, that of which is listed with the description Ranitidine Tablets Usp; Manufactured by Glaxowellcome and listed alongside the NSN 6505012306004, part number NDC00173-0393-40 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-230-6004 Item Description: Ranitidine Tablets Usp | 6505 | 012306004 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc00173-0393-40 | 2 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS RANITIDINE ACTIVE INGREDIENT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 TABLETS |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | RANITIDINE TABLETS USP 300MG 30S BT |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote